FOLLOW US

This story is brought to you by Dr. Robi Ludwig via the USA Herald Platform

As a kid, I was always intrigued with potions and products. My father worked as a scientist, whose specialty was chemistry as well as business. For many years he worked as the Director of Research and Development for the Mennen Company. Perhaps this is where my love of products and researching products began.

Like many women, my skin can be difficult at times. I have eczema which makes it intermittently sensitive, so I have to be careful of the products I use. While researching these products, I also looked into the science supporting them.

As fate would have it while exploring some interesting articles on my Twitter feed recently, I came across an intriguing tweet I just couldn’t ignore. It was a tweet by a glamorous NYC dermatologist who was talking about how excited she was to receive her Lifeline Skin Care products in the mail. Her excitement was so infectious; I decided to look into these products for myself, and looking into them, ultimately led to me buy them.

While researching Lifeline Skin Care’s products, I also looked into the science supporting them. Lifeline Skin Care products use something I had never heard of before; they use human, non-embryonic stem cells as one of the main ingredients to help tone and reduce the signs of aging.

As a therapist, I not only look for products that work well and that I believe in, but also look at the philosophy of the company. Lifeline Skin Care was a socially conscious company and fit that standard.

The original goal for these researchers was to find a cure for diabetes and Parkinson’s disease. These scientists created the first non-embryonic human stem cells. This discovery made finding cures for Parkinson’s disease and corneal disease more promising. Currently, some of ISCO’s most promising research is in the field of Parkinson’s disease.

Parkinson’s disease (PD) is a long-term degenerative disease of the central nervous system. It mainly affects the motor system and its symptoms usually have a slow-onset. In early stages, the disease is characterized by shaking, slow movement, difficulty in walking, and rigidity. In time, thinking and behavioral problems may occur. Advanced stages of the disease bring dementia.

There is no cure for PD. Worldwide, over 10 million people are afflicted with PD and the yearly mortality rate is greater than 100,000, globally.

International Stem Cell Corporation (ISCO), is the parent company of Lifeline Skin Care and has devoted many years of research to improve this terrible disease. The company has developed a unique method of creating human neural stem cells which when introduced into the brain, promote the recovery of dopaminergic neurons, the brain cells that are originally affected and cause the disease symptoms. ISCO’s preclinical studies showed that the administration of these neural stem cells was safe and improved motor symptoms. To date, 3 of the planned total of 12 patients, have entered the clinical trial and have received neural stem cells. At this point in time, all patients have been discharged from their hospital settings and are observed to be meeting clinical expectations.